Deccan Health Care Limited - pharma in Nampally, Telangana, India. FY 2026 financials and compliance.
CIN L72200TG1996PLC024351 Incorporated 14 June 1996 ROC Hyderabad HQ Nampally, Telangana, India
Active Listed - BSE: 542248 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹81.9 Cr
▲ 9.12% YoY
Computed EBITDA · FY 2026
₹5.1 Cr
▲ 61.41% YoY
Net profit · FY 2026
₹2.49 Cr
▲ 114.69% YoY
Authorised capital
₹26 Cr
Registered with MCA
Paid-up capital
₹24.75 Cr
Issued & subscribed
Open charges
₹3.46 Cr
Satisfied ₹20.4 Cr
Company age
30 yrs
Est. 1996
Employees · EPFO
3
Latest available

About Deccan Health Care Limited

Data last updated: 14 July 2026

Deccan Health Care Limited is a public limited company based in Nampally, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 14 June 1996, the company has been in operation for over 30 years.

Registered with ROC Hyderabad under CIN L72200TG1996PLC024351. Listed on BSE: 542248.

Capital: an authorised share capital of ₹26 Cr and a paid-up capital of ₹24.75 Cr. Formerly known as Deccan Health Care Limited and Deccan Health Care Private Limited. It is led by directors including Ruchi Khattar and Ravi Ramprasad.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Nampally, Telangana.

As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹81.9 Cr, a growth of 9.12% compared to the previous year. The net worth stands at ₹110.26 Cr (up 3.64% YoY). Total assets are valued at ₹148.91 Cr (up 19.2% YoY).

The company has a workforce of approximately 3 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Deccan Healthcare. As per MCA filings, the company has open charges of ₹3.46 Cr and satisfied charges of ₹20.4 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website deccanhealthcare.co.in.

Company Details of Deccan Health Care Limited
CIN L72200TG1996PLC024351
Registration Number 024351
Incorporation Date 14 June 1996
ROC Hyderabad
Listing Status Listed (BSE: 542248)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    6 – 3 – 347/17/5/A/Back Position, Dwarakapuri Colony, Nampally, Telangana, India – 500082
  • Industry
    Pharma, Drug Formulation & Development
Company report
Deccan Health Care Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Deccan Health Care Limited report

Financials, compliance, directors, charges, ownership and filings for Deccan Health Care Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Deccan Health Care Limited

Deccan Health Care Limited has undergone 2 name changes throughout its history. The company was previously known as Deccan Health Care Limited, and Deccan Health Care Private Limited. The current legal name is Deccan Health Care Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Deccan Health Care Limited Current
Deccan Health Care Private Limited Previous

CIN History of Deccan Health Care Limited

Deccan Health Care Limited has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L72200TG1996PLC024351, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L72200TG1996PLC024351 Current
U72200AP1996PLC024351 Previous
U72200TG1996PTC024351 Previous
U72200TG1996PLC024351 Previous
U72200AP1996PTC024351 Previous

Associated Brands with Deccan Health Care Limited

Deccan Health Care Limited operates one associated brand: Deccan Healthcare. These brands represent Deccan Health Care Limited's diversified market presence and brand portfolio.

Brand Description Website
Dietary supplements and vitamins are provided for healthy lifestyles. deccanhealthcare.co.in

Competitors & Alternatives of Deccan Health Care Limited

Brands and companies operating in the same space as Deccan Health Care Limited include Kingdomway, Kappa Bioscience, Natto Pharma and 2 more.

Competitor Description Location Founded
Kingdomway Kingdomway Nutraceutical ingredients including DHA and ARA are manufactured by Kingdomway. Xiamen, China, China 1997
Kappa Bioscience Kappa Bioscience Provider of nutraceutical and vitamin ingredients Oslo, Norway, Norway 2006
Natto Pharma Natto Pharma Patented vitamin K2 ingredients are manufactured and marketed. Oslo, Norway, Norway 2004
AudiaCare AudiaCare Vitamins, proteins, and organic products are manufactured by AudiaCare. Glen Gardner, United States, United States 2017
Pura Vida Health Pura Vida Health Non-profit organization promoting digital art, cultural events, and technology innovation. Farmingdale, United States, United States 2017

Business Activity of Deccan Health Care Limited

Deccan Health Care Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Deccan Health Care Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Deccan Health Care Limited

Deccan Health Care Limited is audited by Keyur Shah & Associates (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Keyur Shah & Associates (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Deccan Health Care Limited

Deccan Health Care Limited is currently managed by 11 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Ruchi Khattar Director 24 Sep 2020 5 Years 9 Months Current
Ravi Ramprasad Director 02 Sep 2022 3 Years 10 Months Current
Minto Purshotam Gupta Managing Director 06 Feb 2000 26 Years 5 Months Current
Meenakshi Gupta Director 29 Oct 2014 11 Years 8 Months Current
Viraj Shaileshkumar Shah Director 13 Mar 2023 3 Years 4 Months Current
Mohak Gupta Whole-Time Director 11 Apr 2025 1 Years 3 Months Current
Showing 6 of 11 current directors. View all directors

Financials of Deccan Health Care Limited FY 2026 filings available

Deccan Health Care Limited reported revenue of ₹81.9 Cr (up 9.12% YoY) for FY 2026.

Revenue · FY 2026
₹81.9 Cr ▲ 9.12%
Profit · FY 2026
₹2.49 Cr ▲ 114.69%
Computed EBITDA · FY 2026
₹5.1 Cr ▲ 61.41%
Revenue₹ Cr · Consolidated050100FY 2021: ₹34 Cr33.8FY 2021FY 2022: ₹33 Cr · -1.8% YoY33.2-1.8%FY 2022FY 2023: ₹45 Cr · +35.7% YoY45+35.7%FY 2023FY 2024: ₹60 Cr · +32.7% YoY59.7+32.7%FY 2024FY 2025: ₹75 Cr · +25.7% YoY75.1+25.7%FY 2025FY 2026: ₹82 Cr · +9.1% YoY81.9+9.1%FY 2026
Net Profit₹ Cr · Consolidated0123FY 2021: ₹0 Cr0.4FY 2021FY 2022: ₹0 Cr · -17.3% YoY0.3-17.3%FY 2022FY 2023: ₹0 Cr · +12.8% YoY0.4+12.8%FY 2023FY 2024: ₹1 Cr · +310.1% YoY1.5+310.1%FY 2024FY 2025: ₹1 Cr · -22.4% YoY1.2-22.4%FY 2025FY 2026: ₹2 Cr · +114.7% YoY2.5+114.7%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0102030Q1'25: ₹13 Cr13.2Q1'25Q2'25: ₹19 Cr18.8Q2'25Q3'25: ₹20 Cr20.4Q3'25Q4'25: ₹21 Cr20.7Q4'25Q1'26: ₹22 Cr · +67.9% YoY22.1+67.9%Q1'26Q2'26: ₹21 Cr · +13.7% YoY21.4+13.7%Q2'26Q3'26: ₹17 Cr · -14.9% YoY17.4-14.9%Q3'26Q4'26: ₹21 Cr · +1.1% YoY21+1.1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue from Operations ₹81.9 Cr ₹75.06 Cr ₹59.73 Cr ₹45.02 Cr ₹33.17 Cr ₹33.78 Cr
Other Income ₹87,000 ₹57,000 ₹1.47 Lakh ₹1.94 Lakh ₹22.07 Lakh ₹5.54 Lakh
Total Income ₹81.91 Cr ₹75.06 Cr ₹59.74 Cr - - -
Cost of Materials Consumed ₹52.66 Cr ₹40.89 Cr ₹30.46 Cr ₹31.96 Cr ₹3.98 Cr ₹22.74 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹2.28 Cr ₹6.61 Cr ₹7.02 Cr -₹7 Cr ₹10.37 Cr -₹4.31 Cr
Employee Benefit Expense ₹5.34 Cr ₹4.44 Cr ₹3.52 Cr ₹3.25 Cr ₹2.2 Cr ₹2.92 Cr
Finance Costs ₹36.63 Lakh ₹7.42 Lakh ₹8.5 Lakh ₹10.96 Lakh ₹15.18 Lakh ₹10.79 Lakh
Depreciation & Amortisation ₹1.46 Cr ₹1.45 Cr ₹1.47 Cr - - -
Other Expenses ₹21.1 Cr ₹19.97 Cr ₹14.97 Cr ₹14.77 Cr ₹11.28 Cr ₹10.39 Cr
Total Expenses ₹78.65 Cr ₹73.43 Cr ₹57.53 Cr ₹44.52 Cr ₹29.45 Cr ₹33.31 Cr
Profit Before Exceptional Items & Tax ₹3.27 Cr ₹1.63 Cr ₹2.21 Cr - - -
Exceptional Items ₹0 ₹0 ₹0 - - -
Profit Before Tax ₹3.27 Cr ₹1.63 Cr ₹2.21 Cr ₹51.72 Lakh ₹54.25 Lakh ₹51.91 Lakh
Total Tax Expense ₹77.81 Lakh ₹47.15 Lakh ₹72.12 Lakh ₹15.32 Lakh ₹21.99 Lakh ₹12.92 Lakh
Net Profit ₹2.49 Cr ₹1.16 Cr ₹1.49 Cr ₹36.4 Lakh ₹32.26 Lakh ₹38.99 Lakh
  attributable to Owners ₹0 - - - - -
  attributable to NCI ₹0 - - - - -
Other Comprehensive Income -₹1.13 Lakh ₹15.22 Lakh -₹8,000 - - -
Total Comprehensive Income ₹2.48 Cr ₹1.31 Cr ₹1.49 Cr - - -
EBITDA (computed) ₹5.1 Cr ₹3.16 Cr ₹3.77 Cr - - -
Basic EPS ₹1.01 ₹0.54 ₹0.80 - - -
Diluted EPS ₹1.01 ₹0.45 ₹0.80 - - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Total Assets ₹148.91 Cr ₹124.93 Cr ₹108.05 Cr ₹96.85 Cr ₹90.63 Cr ₹92.27 Cr
Non-current Assets ₹19.18 Cr ₹18.69 Cr ₹19.86 Cr ₹21 Cr ₹22.67 Cr ₹25.81 Cr
Current Assets ₹129.73 Cr ₹106.24 Cr ₹88.18 Cr ₹75.86 Cr ₹67.96 Cr ₹66.46 Cr
Property, Plant & Equipment ₹15 Cr ₹14.37 Cr ₹15.68 Cr - - -
Inventories ₹46.96 Cr ₹42.6 Cr ₹45.7 Cr ₹46.75 Cr ₹46.5 Cr ₹44.98 Cr
Trade Receivables ₹16.99 Cr ₹12.54 Cr ₹9.89 Cr - - -
Cash & Equivalents ₹1.64 Cr ₹3.55 Cr ₹2.6 Cr ₹1.43 Cr ₹2.67 Cr ₹3.09 Cr
Equity (Net Worth) ₹110.26 Cr ₹106.39 Cr ₹96.91 Cr - - -
Equity Share Capital ₹24.75 Cr ₹23.43 Cr ₹20.38 Cr - - -
Borrowings (Non-current) ₹2.7 Cr ₹88.43 Lakh ₹1.68 Cr - - -
Borrowings (Current) ₹1.26 Cr ₹26.12 Lakh ₹21.77 Lakh - - -
Total Debt (computed) ₹3.96 Cr ₹1.15 Cr ₹1.9 Cr - - -
Current Liabilities ₹34.05 Cr ₹15.7 Cr ₹7.5 Cr ₹11.98 Cr ₹10.49 Cr ₹12.71 Cr
Total Liabilities ₹38.65 Cr ₹18.54 Cr ₹11.13 Cr - - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹3.62 Cr -₹6.43 Cr -₹12.55 Cr -₹6.61 Cr -₹57.3 Lakh
Investing Cash Flow -₹2.25 Cr -₹57,000 -₹29.98 Lakh ₹25.1 Lakh -₹4.94 Lakh
Financing Cash Flow ₹3.96 Cr ₹7.38 Cr ₹14.04 Cr ₹5.12 Cr ₹6.73 Lakh
Capital Expenditure ₹2.57 Cr ₹0 ₹31.1 Lakh - -
Free Cash Flow (computed) -₹6.19 Cr -₹6.43 Cr -₹12.86 Cr - -
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹1.91 Cr ₹95.12 Lakh ₹1.19 Cr -₹1.23 Cr -₹55.51 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹20.98 Cr ₹17.39 Cr ₹21.4 Cr ₹22.14 Cr ₹20.75 Cr ₹20.43 Cr ₹18.82 Cr ₹13.19 Cr
Other Income ₹8,000 ₹4,000 ₹13,000 ₹62,000 ₹46,000 ₹0 ₹11,000 ₹0
Total Income ₹20.98 Cr ₹17.39 Cr ₹21.4 Cr ₹22.15 Cr ₹20.75 Cr ₹20.43 Cr ₹18.82 Cr ₹13.19 Cr
Cost of Materials Consumed ₹15.82 Cr ₹5.16 Cr ₹12.57 Cr ₹19.12 Cr ₹11.74 Cr ₹12.1 Cr ₹10.75 Cr ₹6.3 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹3.4 Cr ₹4.64 Cr ₹9.42 Lakh -₹3.61 Cr ₹2.28 Cr ₹1.26 Cr ₹61.35 Lakh ₹2.45 Cr
Employee Benefit Expense ₹1.21 Cr ₹1.27 Cr ₹1.47 Cr ₹1.39 Cr ₹1.14 Cr ₹1.05 Cr ₹1.32 Cr ₹93.28 Lakh
Finance Costs ₹14.33 Lakh ₹4.15 Lakh ₹16.43 Lakh ₹1.72 Lakh ₹1.51 Lakh ₹1.74 Lakh ₹2.52 Lakh ₹1.65 Lakh
Depreciation & Amortisation ₹38.11 Lakh ₹34.98 Lakh ₹32.72 Lakh ₹40.55 Lakh ₹35.95 Lakh ₹36.63 Lakh ₹36.66 Lakh ₹36.02 Lakh
Other Expenses ₹6.45 Cr ₹4.6 Cr ₹5.55 Cr ₹4.5 Cr ₹4.98 Cr ₹5.44 Cr ₹5.03 Cr ₹2.64 Cr
Total Expenses ₹20.61 Cr ₹16.05 Cr ₹20.17 Cr ₹21.81 Cr ₹20.52 Cr ₹20.23 Cr ₹18.11 Cr ₹12.7 Cr
Profit Before Exceptional Items & Tax ₹36.7 Lakh ₹1.34 Cr ₹1.23 Cr ₹33.39 Lakh ₹23.49 Lakh ₹19.93 Lakh ₹70.96 Lakh ₹48.64 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹36.7 Lakh ₹1.34 Cr ₹1.23 Cr ₹33.39 Lakh ₹23.49 Lakh ₹19.93 Lakh ₹70.96 Lakh ₹48.64 Lakh
Total Tax Expense ₹3.3 Lakh ₹33.69 Lakh ₹31.14 Lakh ₹9.68 Lakh ₹11.14 Lakh ₹5.5 Lakh ₹18.11 Lakh ₹12.4 Lakh
Net Profit ₹33.4 Lakh ₹1 Cr ₹91.4 Lakh ₹23.71 Lakh ₹12.35 Lakh ₹14.43 Lakh ₹52.85 Lakh ₹36.24 Lakh
  attributable to Owners ₹0 - ₹0 - - ₹0 - -
  attributable to NCI ₹0 - ₹0 - - ₹0 - -
Other Comprehensive Income -₹12.54 Lakh ₹3.8 Lakh ₹3.81 Lakh ₹3.8 Lakh ₹15.28 Lakh -₹2,000 -₹3,000 -₹1,000
Total Comprehensive Income ₹20.86 Lakh ₹1.04 Cr ₹95.21 Lakh ₹27.51 Lakh ₹27.63 Lakh ₹14.41 Lakh ₹52.82 Lakh ₹36.23 Lakh
EBITDA (computed) ₹89.14 Lakh ₹1.73 Cr ₹1.72 Cr ₹75.66 Lakh ₹60.95 Lakh ₹58.3 Lakh ₹1.1 Cr ₹86.31 Lakh
Basic EPS ₹0.14 ₹0.41 ₹0.37 ₹0.10 ₹0.05 ₹0.07 ₹0.26 ₹0.18
Diluted EPS ₹0.14 ₹0.41 ₹0.37 ₹0.10 ₹0.05 ₹0.06 ₹0.21 ₹0.18
Latest 8 quarters shown.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2020
Revenue from Operations ₹89.17 Cr ₹75.13 Cr ₹59.73 Cr ₹45.02 Cr ₹33.17 Cr ₹42.24 Cr
Other Income ₹87,000 ₹57,000 ₹1.37 Lakh ₹1.64 Lakh ₹22.07 Lakh ₹5.72 Lakh
Total Income ₹89.18 Cr ₹75.14 Cr ₹59.74 Cr - - -
Cost of Materials Consumed ₹62.92 Cr ₹40.96 Cr ₹30.46 Cr ₹31.96 Cr ₹3.98 Cr ₹23.39 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹2.28 Cr ₹6.61 Cr ₹7.02 Cr -₹7 Cr ₹10.37 Cr -₹6.64 Cr
Employee Benefit Expense ₹5.25 Cr ₹4.35 Cr ₹3.41 Cr ₹3.16 Cr ₹2.2 Cr ₹4.33 Cr
Finance Costs ₹36.61 Lakh ₹7.39 Lakh ₹6.35 Lakh ₹10.92 Lakh ₹15.18 Lakh ₹18.32 Lakh
Depreciation & Amortisation ₹1.46 Cr ₹1.45 Cr ₹1.47 Cr - - -
Other Expenses ₹18.4 Cr ₹20.02 Cr ₹15.08 Cr ₹14.76 Cr ₹11.28 Cr ₹9.49 Cr
Total Expenses ₹86.12 Cr ₹73.47 Cr ₹57.5 Cr ₹44.43 Cr ₹29.45 Cr ₹32.17 Cr
Profit Before Exceptional Items & Tax ₹3.06 Cr ₹1.67 Cr ₹2.24 Cr - - -
Exceptional Items ₹0 ₹0 ₹0 - - -
Profit Before Tax ₹3.06 Cr ₹1.67 Cr ₹2.24 Cr ₹60.88 Lakh ₹54.4 Lakh ₹10.13 Cr
Total Tax Expense ₹76.54 Lakh ₹47.13 Lakh ₹72.12 Lakh ₹15.32 Lakh ₹21.99 Lakh ₹4.44 Lakh
Net Profit ₹2.29 Cr ₹1.2 Cr ₹1.52 Cr ₹45.56 Lakh ₹32.41 Lakh ₹10.09 Cr
Other Comprehensive Income -₹1.13 Lakh ₹15.22 Lakh -₹8,000 - - -
Total Comprehensive Income ₹2.28 Cr ₹1.35 Cr ₹1.52 Cr - - -
EBITDA (computed) ₹4.89 Cr ₹3.2 Cr ₹3.77 Cr - - -
Basic EPS ₹0.93 ₹0.56 ₹0.82 - - -
Diluted EPS ₹0.93 ₹0.47 ₹0.82 - - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2020
Total Assets ₹144.12 Cr ₹123.93 Cr ₹107.33 Cr ₹96.54 Cr ₹90.63 Cr ₹92.99 Cr
Non-current Assets ₹19.18 Cr ₹18.69 Cr ₹19.87 Cr ₹21.01 Cr ₹22.68 Cr ₹27.13 Cr
Current Assets ₹124.94 Cr ₹105.24 Cr ₹87.45 Cr ₹75.53 Cr ₹67.95 Cr ₹65.86 Cr
Property, Plant & Equipment ₹15 Cr ₹14.37 Cr ₹15.68 Cr - - -
Inventories ₹39.76 Cr ₹42.53 Cr ₹45.7 Cr ₹46.75 Cr ₹46.5 Cr ₹37.9 Cr
Trade Receivables ₹23.72 Cr ₹12.61 Cr ₹9.89 Cr - - -
Cash & Equivalents ₹1.62 Cr ₹3.49 Cr ₹2.22 Cr ₹1.39 Cr ₹2.66 Cr ₹3.34 Cr
Equity (Net Worth) ₹110.22 Cr ₹106.55 Cr ₹97.04 Cr - - -
Equity Share Capital ₹24.75 Cr ₹23.43 Cr ₹20.38 Cr - - -
Borrowings (Non-current) ₹2.7 Cr ₹88.43 Lakh ₹1.19 Cr - - -
Borrowings (Current) ₹1.26 Cr ₹26.12 Lakh ₹21.77 Lakh - - -
Total Debt (computed) ₹3.96 Cr ₹1.15 Cr ₹1.41 Cr - - -
Current Liabilities ₹29.3 Cr ₹14.54 Cr ₹7.14 Cr ₹12.37 Cr ₹10.49 Cr ₹13.6 Cr
Total Liabilities ₹33.9 Cr ₹17.38 Cr ₹10.29 Cr - - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹3.59 Cr -₹6.59 Cr -₹12.48 Cr -₹5.85 Cr -₹57.22 Lakh
Investing Cash Flow -₹2.25 Cr -₹1.79 Lakh -₹29.98 Lakh ₹25.09 Lakh -₹4.94 Lakh
Financing Cash Flow ₹3.97 Cr ₹7.88 Cr ₹13.64 Cr ₹4.33 Cr ₹6.73 Lakh
Capital Expenditure ₹2.57 Cr ₹0 ₹31.1 Lakh - -
Free Cash Flow (computed) -₹6.15 Cr -₹6.59 Cr -₹12.79 Cr - -
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹1.87 Cr ₹1.27 Cr ₹86.05 Lakh -₹1.27 Cr -₹55.43 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹20.26 Cr ₹23.03 Cr ₹24.4 Cr ₹21.47 Cr ₹20.82 Cr ₹20.43 Cr ₹18.82 Cr ₹13.19 Cr
Other Income ₹8,000 ₹4,000 ₹13,000 ₹62,000 ₹46,000 ₹0 ₹11,000 ₹0
Total Income ₹20.27 Cr ₹23.03 Cr ₹24.41 Cr ₹21.48 Cr ₹20.83 Cr ₹20.43 Cr ₹18.82 Cr ₹13.19 Cr
Cost of Materials Consumed ₹16.59 Cr ₹11.45 Cr ₹15.83 Cr ₹19.05 Cr ₹11.82 Cr ₹12.1 Cr ₹10.75 Cr ₹6.3 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹3.4 Cr ₹4.64 Cr ₹9.42 Lakh -₹3.61 Cr ₹2.28 Cr ₹1.26 Cr ₹61.35 Lakh ₹2.45 Cr
Employee Benefit Expense ₹1.19 Cr ₹1.25 Cr ₹1.45 Cr ₹1.36 Cr ₹1.12 Cr ₹1.02 Cr ₹1.3 Cr ₹90.84 Lakh
Finance Costs ₹14.33 Lakh ₹4.14 Lakh ₹16.43 Lakh ₹1.71 Lakh ₹1.5 Lakh ₹1.73 Lakh ₹2.51 Lakh ₹1.65 Lakh
Depreciation & Amortisation ₹38.11 Lakh ₹34.98 Lakh ₹32.72 Lakh ₹40.55 Lakh ₹35.95 Lakh ₹36.63 Lakh ₹36.66 Lakh ₹36.02 Lakh
Other Expenses ₹5.11 Cr ₹4.02 Cr ₹5.32 Cr ₹3.95 Cr ₹4.99 Cr ₹5.45 Cr ₹5.05 Cr ₹2.66 Cr
Total Expenses ₹20.02 Cr ₹21.74 Cr ₹23.19 Cr ₹21.17 Cr ₹20.58 Cr ₹20.22 Cr ₹18.1 Cr ₹12.69 Cr
Profit Before Exceptional Items & Tax ₹24.78 Lakh ₹1.29 Cr ₹1.22 Cr ₹30.11 Lakh ₹24.72 Lakh ₹21.07 Lakh ₹71.84 Lakh ₹49.29 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹24.78 Lakh ₹1.29 Cr ₹1.22 Cr ₹30.11 Lakh ₹24.72 Lakh ₹21.07 Lakh ₹71.84 Lakh ₹49.29 Lakh
Total Tax Expense ₹2.03 Lakh ₹33.69 Lakh ₹31.96 Lakh ₹8.86 Lakh ₹11.12 Lakh ₹5.5 Lakh ₹18.11 Lakh ₹12.4 Lakh
Net Profit ₹22.75 Lakh ₹95.07 Lakh ₹89.97 Lakh ₹21.25 Lakh ₹13.6 Lakh ₹15.57 Lakh ₹53.73 Lakh ₹36.89 Lakh
Other Comprehensive Income -₹12.54 Lakh ₹3.8 Lakh ₹3.81 Lakh ₹3.8 Lakh ₹15.28 Lakh -₹2,000 -₹3,000 -₹1,000
Total Comprehensive Income ₹10.21 Lakh ₹98.87 Lakh ₹93.78 Lakh ₹25.05 Lakh ₹28.88 Lakh ₹15.55 Lakh ₹53.7 Lakh ₹36.88 Lakh
EBITDA (computed) ₹77.22 Lakh ₹1.68 Cr ₹1.71 Cr ₹72.37 Lakh ₹62.17 Lakh ₹59.43 Lakh ₹1.11 Cr ₹86.96 Lakh
Basic EPS ₹0.09 ₹0.38 ₹0.36 ₹0.09 ₹0.06 ₹0.07 ₹0.26 ₹0.18
Diluted EPS ₹0.09 ₹0.38 ₹0.36 ₹0.09 ₹0.05 ₹0.06 ₹0.21 ₹0.18
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Deccan Health Care Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Deccan Health Care Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 19.46%, domestic institutional investors hold 5.68%, retail and other public shareholders hold 74.86% of Deccan Health Care Limited. The company had 4,004 shareholders on record.

Promoters: 19.46%DII (Domestic Institutional): 5.68%Retail & Others: 74.86%
Mar 2026
QUARTER
19.46% Promoters
5.68% DII (Domestic Institutional)
74.86% Retail & Others
Promoter holding - history
Now 19.46% · Mar 2026High 19.46% · Mar 2025Low 15.66% · Sep 2024
14%15.8%17.5%19.3%21%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 19.27%Sep 2023: 19.27%Dec 2023: 16.12%Mar 2024: 16.12%Jun 2024: 16.12%Sep 2024: 15.66%Dec 2024: 18.26%Mar 2025: 19.46%Jun 2025: 18.42%Sep 2025: 18.42%Dec 2025: 18.42%Mar 2026: 19.46%19.46%15.66%19.46%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters19.46%18.42%18.42%18.42%19.46%18.26%
Public80.54%81.58%81.58%81.58%80.54%81.74%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters19.46%19.46%16.12%
Public80.54%80.54%83.88%
Promoter change (YoY, %pts)+0.00+3.34-

Group Structure of Deccan Health Care Limited

Deccan Health Care Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Deccan Health Care Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Beyoungstore Private Limited U74999TG2020PTC140313 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Deccan Health Care Limited

Open charges
₹3.46 Cr
Satisfied charges
₹20.4 Cr
Breakdown by lending institutions
Bank of India₹2.26 Cr
Hdfc Bank Limited₹1.20 Cr
Latest charge details
DateLenderAmountStatus
13 Oct 2025 Bank of India ₹20.9 Lakh Open
13 Oct 2025 Bank of India ₹25.1 Lakh Open
24 Sep 2025 Bank of India ₹1.8 Cr Open
27 Dec 2023 Hdfc Bank Limited ₹31.35 Lakh Open
30 Jun 2021 Hdfc Bank Limited ₹88.6 Lakh Open

Total charge records: 11 View all charges

Employees and EPFO Compliance at Deccan Health Care Limited

Deccan Health Care Limited has a workforce of 3 employees as of Mar 23, 2024.

Employee count
3
Active EPFO establishments
1
Employee growth
-50%
Premium access

Employee and EPFO history for Deccan Health Care Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Deccan Health Care Limited

Premium access

GST registrations and filing compliance for Deccan Health Care Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Deccan Health Care Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Deccan Health Care Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Deccan Health Care Limited

Premium access

MSME payment history for Deccan Health Care Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Deccan Health Care Limited

Premium access

Corporate group structure for Deccan Health Care Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Deccan Health Care Limited

Premium access

MCA filings and documents for Deccan Health Care Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Deccan Health Care Limited

Charges
05 Jun 2026
A charge registered on 18 Jul 2025 via Charge ID 101143784 with Others was fully satisfied on 05 Jun 2026.
Directors
27 Apr 2026
Shikha Das was appointed as a Company Secretary on 27 Apr 2026 & has been associated with this company since 2 months 26 days.
Directors
25 Apr 2026
Pratiksha Bisht was appointed as a Additional Director on 25 Apr 2026 & has been associated with this company since 2 months 28 days.
Directors
25 Apr 2026
Manju Singh was appointed as a Additional Director on 25 Apr 2026 & has been associated with this company since 2 months 28 days.
Directors
25 Apr 2026
Bhupendra Singh Kataria was appointed as a Additional Director on 25 Apr 2026 & has been associated with this company since 2 months 28 days.
Charges
13 Oct 2025
A charge with Bank Of India amounted to Rs. 0.21 Cr with Charge ID 101181889 was registered on 13 Oct 2025.

Recent News on Deccan Health Care Limited

Frequently Asked Questions about Deccan Health Care Limited

Deccan Health Care Limited is an active public limited company in the pharma sector based in Nampally, Telangana, India. It was incorporated on 14 June 1996 (30+ years old) and is registered under CIN L72200TG1996PLC024351. Listed on BSE: 542248. The company has 3 employees.

Deccan Health Care Limited reported revenue of ₹81.9 Cr for FY 2026 (up 9.12% YoY) based on consolidated BSE filings.

The current directors of Deccan Health Care Limited are:

The primary industry of Deccan Health Care Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Deccan Health Care Limited is listed on BSE with code 542248.

Deccan Health Care Limited can be reached at the registered office: 6 – 3 – 347175ABack Position, Dwarakapuri Colony, Nampally, Telangana, India – 500082, or through the website deccanhealthcare.co.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available